1. Home
  2. AXGN vs MIN Comparison

AXGN vs MIN Comparison

Compare AXGN & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXGN
  • MIN
  • Stock Information
  • Founded
  • AXGN N/A
  • MIN 1988
  • Country
  • AXGN United States
  • MIN United States
  • Employees
  • AXGN N/A
  • MIN N/A
  • Industry
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MIN Trusts Except Educational Religious and Charitable
  • Sector
  • AXGN Health Care
  • MIN Finance
  • Exchange
  • AXGN Nasdaq
  • MIN Nasdaq
  • Market Cap
  • AXGN 584.7M
  • MIN 315.8M
  • IPO Year
  • AXGN N/A
  • MIN N/A
  • Fundamental
  • Price
  • AXGN $13.15
  • MIN $2.72
  • Analyst Decision
  • AXGN Strong Buy
  • MIN
  • Analyst Count
  • AXGN 4
  • MIN 0
  • Target Price
  • AXGN $15.00
  • MIN N/A
  • AVG Volume (30 Days)
  • AXGN 370.0K
  • MIN 331.0K
  • Earning Date
  • AXGN 11-05-2024
  • MIN 01-01-0001
  • Dividend Yield
  • AXGN N/A
  • MIN 7.31%
  • EPS Growth
  • AXGN N/A
  • MIN N/A
  • EPS
  • AXGN N/A
  • MIN 0.08
  • Revenue
  • AXGN $173,482,000.00
  • MIN N/A
  • Revenue This Year
  • AXGN $18.49
  • MIN N/A
  • Revenue Next Year
  • AXGN $12.78
  • MIN N/A
  • P/E Ratio
  • AXGN N/A
  • MIN $33.38
  • Revenue Growth
  • AXGN 17.26
  • MIN N/A
  • 52 Week Low
  • AXGN $3.45
  • MIN $2.52
  • 52 Week High
  • AXGN $15.23
  • MIN $2.88
  • Technical
  • Relative Strength Index (RSI)
  • AXGN 44.12
  • MIN 42.59
  • Support Level
  • AXGN $13.08
  • MIN $2.72
  • Resistance Level
  • AXGN $15.23
  • MIN $2.74
  • Average True Range (ATR)
  • AXGN 0.65
  • MIN 0.03
  • MACD
  • AXGN -0.17
  • MIN -0.00
  • Stochastic Oscillator
  • AXGN 12.97
  • MIN 16.67

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

About MIN MFS Intermediate Income Trust

MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.

Share on Social Networks: